Press Information Bureau
Government of India
PIB Headquarters
23 OCT 2021 7:51PM by PIB Delhi

  • 101.30 crore vaccine doses have been administered so far under Nationwide Vaccination Drive
  • 16,326 new cases in the last 24 hours
  • Recovery Rate currently at 98.16%; Highest since March 2020
  • 17,677 recoveries in the last 24 hours increases Total Recoveries to 3,35,32,126
  • Active cases account for less than 1% of total cases, currently at 0.51%; Lowest since March 2020
  • India's Active caseload stands at 1,73,728; lowest in 233 days
  • Weekly Positivity Rate (1.24%) less than 2% for last 29 days
  • Daily positivity rate (1.20%) less than 2% for last 19 days
  • 59.84 crore Total Tests conducted so far













COVID-19 Update

India’s Cumulative COVID-19 Vaccination Coverage exceeds 101.30 Cr

More than 68 Lakh doses administered in last 24 hours

Recovery Rate currently at 98.16%; Highest since March 2020

16,326 New Cases reported in the last 24 hours

India's Active Caseload (1,73,728) is lowest in 233 days

Weekly Positivity Rate (1.24%) less than 2% for last 29 days


With the administration of 68,48,417 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has surpassed 100 Cr mark to reach 101.30 Cr (1,01,30,28,411) as per provisional reports till 7 am today. This has been achieved through 1,00,29,602 sessions.

The break-up of the cumulative figure as per the provisional report till 7 am today include:




1st Dose


2nd Dose




1st Dose


2nd Dose



Age Group 18-44 years

1st Dose


2nd Dose



Age Group 45-59 years

1st Dose


2nd Dose



Over 60 years

1st Dose


2nd Dose





The recovery of 17,677 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,35,32,126.

Consequently, India’s recovery rate stands at 98.16%. Recovery Rate is currently at its highest peak since March 2020.

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 118 consecutive days now.

16,326 new cases were reported in the last 24 hours.

The Active Caseload remains below 2 lakh mark and is presently at 1,73,728 which is lowest in 233 days. Active cases presently constitute 0.51% of the country's total Positive Cases, which is lowest since March 2020.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of

13,64,681 tests being conducted. India has so far conducted over 59.84 Cr (59,84,31,162) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 1.24% remains less than 2% for the last 29 days now. The Daily Positivity rate reported to be 1.20%. The daily Positivity rate has remained below 2% for last 19 days and below 3% for 54 consecutive days now.


Update on COVID-19 Vaccine Availability in States/UTs

More than 105.7 Crore vaccine doses provided to States/UTs

More than 12 Crore balance and unutilized vaccine doses still available with States/UTs

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.




(As on 23rd October 2021)











More than 105.7 crore (1,05,78,05,425) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category.

More than 12 Cr (12,02,54,104) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.


PM interacts with domestic vaccine manufacturers

PM praises the efforts of the vaccine manufacturers which has resulted in India crossing the 100 crore vaccination milestone

PM exhorts that the country needs to institutionalise the best practises learnt during the last one and a half years

Vaccine manufacturers praise the vision and dynamic leadership of PM; applaud the never before seen collaboration between govt & industry


Prime Minister Shri Narendra Modi interacted with the domestic vaccine manufacturers at Lok Kalyan Marg today.

Prime Minister praised the efforts of the vaccine manufacturers, which has resulted in the country crossing the milestone of 100 crore vaccinations, and said that they have played a big role in the success story of India. He appreciated their hard work and confidence given by them during the pandemic.

Prime Minister exhorted that the country needs to institutionalise the best practises learnt during the last one and a half years, and said that this is an opportunity to modify our practises, in tune with the global standards. He said that the entire world is looking up to India, in the backdrop of the success of the vaccination drive. He also said that the vaccine manufacturers should continuously work together to be ready to face future challenges.


Centre Reviews Status and Progress of COVID Vaccination with States/UTs

States/UTs urged to increase Pace and Coverage of Second Dose

States to generate district wise list of beneficiaries for administration of second dose

Advised to draw District-wise Plan involving District Magistrates for saturation of beneficiaries

Shri Rajesh Bhushan, Union Health Secretary reviewed the progress of COVID19 vaccination with Health Secretaries and Mission Directors of National Health Mission (NHM) of States and UTs, through video conference (VC) today. The focus of the meeting was to urge the states and UTs to increase the pace of the countrywide vaccination and coverage of the second dose. This comes in the backdrop of the country achieving the milestone of administering 100 crore doses on 21st October 2021.

Highlighting the sizeable number of eligible beneficiaries who have not received their 2nd dose of vaccine, the Union Health Secretary urged the States and UTs to focus on those beneficiaries who are waiting for their second dose after their interval period has been over.



Important Tweets